Feline immunodeficiency virus vaccination: Characterization of the immune correlates of protection

Journal of Virology

Volumn 70, Issue 11, 1996, Pages 7561-7568

  Hosie, Margaret J ^a,b   Flynn, J Norman ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INACTIVATED VIRUS VACCINE; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN PRESENTING CELL; ARTICLE; CAT; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FELINE IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMORAL IMMUNITY; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VACCINE PRODUCTION; VIREMIA; VIRUS ISOLATION;

EID: 0029820583     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.11.7561-7568.1996     Document Type: Article

References (53)

1. Arthur, L. O., J. W. Bess, R. G. Urban, J. L. Strominger, W. R. Morton, D. L. Mann, L. E. Henderson, and R. E. Benveniste. 1195. Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. J. Virol. 69:3117-3124.
2. Avrameus, A., J.-G. Guillet, L. Chouchane, A. Moraillon, P. Sonigo, and A. D. Strosberg. 1992. Localisation of three epitopes of the env protein of feline immunodeficiency virus. Mol. Immunol. 29:565-572.
3. Beatty, J. A., B. J. Willett, E. A. Gault, and O. Jarret. 1996. A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction. J. Virol. 70: 6199-6206.
4. Borrow, P., H. Lewicki, B. H. Hahn, G. M. Shaw, and M. B. Oldstone. 1994. Virus-specific cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
5. Bryson, Y. J., S. Pang, L. S. Wei, R. Dickover, A. Diagne, and I. S. Y. Chen. 1995. Clearance of HIV infection in a perinatally infected infant. N. Engl. J. Med. 332:833-838.
6. Carlson, J. R., T. P. McGraw, E. Keddie, J. L. Yee, A. Rosenthal, A. J. Langlois, R. Dickover, R. Donovan, P. A. Luciw, M. B. Jennings, and M. B. Gardner. 1990. Vaccine protection of rhesus macaques against simian immunodeficiency virus infection. AIDS Res. Hum. Retroviruses 6:1239-1246.
7. Cheynier, R., P. Langlade-Demoyen, M.-R. Marescot, S. Blanche, G. Blondin, S. Wain-Hobson, C. Griscelli, E. Vilmer, and F. Plata. 1992. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur. J. Immunol. 22: 2211-2217.
8. Clements, J. E., R. C. Montelaro, M. C. Zink, A. M. Amedee, S. Miller, A. M. Trichel, B. Jagerski, D. Hauer, L. N. Martin, R. P. Bohm, and M. MurpheyCorb. 1995. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J. Virol. 69:2737-2744.
9. Crandell, R. A., C. G. Fabricant, and W. A. Nelson-Rees. 1973. Development, characterisation and virus susceptibility of a feline (Felis catus) renal cell line (CRFK). In Vitro 9:176-185.
10. de Ronde, A., J. G. Slam, P. Boers, H. Langedijk, R. Meloen, W. Hesselink, L. C. E. J. M. Keldermans, A. van Vliet, E. J. Verschoor, M. C. Horzinek, and H. K. Egberink. 1993. Antibody response in cats to the envelope proteins of feline immunodeficiency virus: identification of an immunodominant neutralization domain. Virology 198:1-8.
11. Desrosiers, R. C., M. S. Wyand, T. Kodama, D. Ringler, L. Arthur, P. Sehgal, N. Letvin, N. King, and M. Daniel. 1989. Vaccine protection against simian immunodeficiency virus infection. Proc, Natl. Acad. Sci. USA 86:6353-6357.
12. Embretson, J., M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, and A. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages hy HIV during the incubation period of AIDS. Nature (London) 362:359-362.
13. Flynn, J. N., J. A. Beatty, C. A. Cannon, E. B. Stephens, M. J. Hosie, J. C. Neil, and O. Jarrett. 1995. Involvement of gag- and env- specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus. AIDS Res. Hum. Retroviruses 11:1107-1113.
14. Flynn, J. N., C. A. Cannon, J. Beatty, M. Mackett, M. Rigby, J. C. Neil, and O. Jarrett. 1994. Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptide. J. Virol. 68:5835-5844.
15. Flynn, J. N., C. A. Cannon, G. Reid, M. A. Rigby, J. C. Neil, and O. Jarrett. 1995. Induction of feline immunodeficiency virus-specific cell-mediated and humoral immune responses following immunization with a multiple antigenic peptide from the envelope V3 domain. Immunology 85:171-175.
16. Flynn, J. N., P. Keating, M. J. Hosie, M. Mackett, E. B. Stephens, J. A. Beatty, J. C. Neil, and O. Jarrett. Env-specific CTL predominate in cats protected from FIV infection by vaccination. J. Immunol., in press.
17. Heath, S. L., J. G. Tew, A. K. Szakal, and G. F. Burton. 1995. Follicular dendritic cells and human immunodeficiency virus infectivity. Nature (London) 377:740-744.
18. Hohdatsu, T., R. Pu, B. A. Torres, S. Trujillo, M. B. Gardner, and J. K. Yamamoto. 1993. Passive antibody protection of cats against feline immunodeficiency virus infection. J. Virol. 67:2344-2348.
19. Hosie, M., R. Osborne, J. K. Yamamolo, J. C. Neil, and O. Jarrett. 1995. Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. J. Virol. 69:1253-1255.
20. Hosie, M. J., T. H. Dunsford, A de Ronde, B. J. Willett, C. A. Cannon, J. C. Neil, and O. Jarrett. 1996. Suppression of virus burden by immunisation with feline immunodeficiency virus Env protein. Vaccine 14:405-411.
21. Hosie, M. J, and O. Jarrett. 1995. Feline immunodeficiency virus as a vaccine model, p. 85-96. In G. Gregoriadis, B. McCormack, and A. C. Allison (ed.), Vaccines: new generation immunological adjuvants. Plenum Press, New York.
22. Johnson, C., B. Torres, H. Koyama, and J. K. Yamamoto. 1994. FIV as a model for AIDS vaccination. AIDS Res. Hum. Retroviruses 10:225-228.
23. Koup, R. A., J. T. Safrit, J. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency type 1 syndrome. J. Virol. 68:4650-4655.
24. Lombardi, S., C. Garzelli, C. La Rosa, L. Zaccaro, S. Specter, G. Malvaldi, F. Tozzini, F. Esposito, and M. Bendinelli. 1993. Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope. J. Virol. 67:4742-4749.
25. Lombardi, S., C. Garzelli, M. Pistello, C. Massi, D. Matteucci, F. Baldinotti, G. Cammaroto, L. Da Prato, P. Bandecchi, F. Tozzini, and M. Bendinelli. 1994. A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity. J. Virol. 68:8374-8379.
26. Lubaki, M. N., M. A. Egan, R. F. Siliciano, K. J. Weinhold, and R. C. Bollinger. 1996. A novel method for the detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes. AIDS Res. Hum. Retroviruses 11:1427-1431.
27. Matteucci, D. Personal communication.
28. Matteucci, D., M. Pistello, P. Mazzetti, S. Giannecchini, D. Del Mauro, L. Zaccaro, P. Bandecchi, F. Tozzini, and M. Bendinelli. 1996. Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies. J. Virol. 70:617-622.
29. Miyazawa, T. M., T. Furuya, S. Itagaki, Y. Tohya, E. Takahashi, and T. Mikami. 1989. Establishment of a feline T-lymphoblastoid cell line highly sensitive for replication of feline immunodeficiency virus. Arch. Virol. 108: 131-135.
30. Murphey-Corb, M., L. N. Martin, B. Davison-Fairburn, R. C. Montelaro, M. Miller, M. West, S. Ohkawa, G. B. Baskin, J. Zhang, S. D. Putney, A. C. Allison, and D. A. Eppstein. 1989. A formalin inactivated virus confers protection in macaques. Science 246:1293-1297.
31. Newell, M.-L., D. Dunn, A. De Maria, A. Ferrazin, A. De Rossi, C. Giaquinto, J. Levy, A Alimenti, A. Ehrnst, A-B. Bohlin, R. Ljung, and C. Peckham. 1996. Detection of virus in vertically exposed HIV-antibody-negative children. Lancet 347:213-215.
32. Nixon, D. F. 1992. The cytotoxic T cell response to HIV, p. 59-89. In G. Bird (ed.), Immunology of HIV, Kluwer Academic Publishers, Liverpool, United Kingdom.
33. Nixon, D. F., K. Broliden, G. Ogg, and P.-A. Proliden. 1992. Cellular and humoral antigenic epitopes in HIV and SIV. Immunology 76:515-534.
34. Nixon, D. F., A. R. M. Townsend, J. G. Elvin, C. R. Rizza, J. Gallway, and A. J. McMichael. 1988. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature (London) 336:484-487.
35. Osborne, R., M. Rigby, K. Siebelink, J. C. Neil, and O. Jarrett 1994. Virus neutralization reveals antigenic variation among feline immunodeficiency virus isolates. J. Gen. Virol. 75:3641-3645.
36. Pantaleo, G., J. F. Demarest, and H. Soudeyns. 1994. Major expansion of CD8+ T cells with a predominant V-beta usage during the primary immune response to HIV. Nature (London) 370:463-467.
37. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, C. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (London) 362:355-358.
38. Rigby, M. R., N. Mackay, G. Reid, R. Osborne, J. C. Neil, and O. Jarrett. Immunogenicity of a peptide from a major neutralising determinant of the feline immunodeficiency virus surface glycoprotein. Vaccine, in press.
39. Rowland-Jones, S. L., D. F. Nixon, M. C. Aldhous, F. Gotch, K. Ariyoshi, N. Hallam, J. S. Kroll, K. Froebel, and A. McMichael. 1993. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 241:860-861.
40. Rowland-Jones, S. L., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schulz, A. McMichael, and H. Whittle. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59-64.
41. Sethi, K. K., H. Naher, and I. Stroehmann. 1988. Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell clones. Nature (London) 335:178-181.
42. Sibille, P., A. Avrameas, A. Moraillon, J. Richardson, P. Sonigo, G. Pancino, and A. D. Strosberg. 1995. Comparison of serological tests for the diagnosis of feline immunodeficiency virus infection of cats. Vet. Microbiol. 45:259-267.
43. Siebelink, K. H. J., G. F. Rjmmelzwaan, M. L. Bosch, R. H. Melden, and A. D. M. E. Osterhaus. 1993. A single amino acid substitution in hypervariable region 5 of the envelope protein of feline immunodeficiency virus allows escape from virus neutralization. J. Virol. 67:2202-2208.
44. Stephens, E. B., E. J. Butfiloski, and E. Monck. 1992. Analysis of the amino terminal presequence of the feline immunodeficiency virus glycoprotein: effect of deletions on the intracellular transport of gp95. Virology 190:569-578.
45. Stott, E. J. 1991. Anti-cell antibody in macaques. Nature (London) 353:393.
46. van Baalen, C. A., M. R. Klein, A. M. Geretti, R. I. P. M. Keet, F. Miedema, C. A. C. M. van Els, and A. D. M. E. Osterhaus. 1993. Selective in vitro expansion of HLA class-I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies. AIDS 7:781-786.
47. Willett, B., M. J. Hosie, T. Dunsford, J. C. Neil, and O. Jarrett. 1991. Productive infection of helper T lymphocytes with FIV is accompanied by reduced expression of CD4. AIDS 5:1469-1475.
48. Willett, B. J., and M. J. Hosie. 1995. Feline immunodeficiency virus and cell tropism, p. 205-219. In B. J. Willett and O. Jarrett (ed.), Feline immunology and immunodeficiency. Oxford University Press, Oxford.
49. Wyand, M. S., K. H. Manson, M. Garcia-Moll, D. Montefiori, and R. C. Desrosiers. 1996. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70:3724-3733.
50. Yamamoto, J. K., C. D. Ackley, H. Zochlinski, H. Louie, E. Pembroke, M. Torten, H. Hansen, R. Munn, and T. Okuda. 1991. Development of IL-2-independent feline lymphoid cell lines chronically infected with feline immunodeficiency viruses: importance for diagnostic reagents and vaccines. Intervirology 32:361-375.
51. Yamamoto, J. K., T. Hohdatsu, R. A. Olmsted, R. Pu, H. Louie, H. Zochlinski, V. Acevedo, H. M. Johnson, G. Soulds, and M. Gardner. 1993. Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J. Virol. 67:601-605.
52. Yamamoto, J. K., T. Okuda, C. D. Ackley, H. Louie, E. Pembroke, H. Zochlinski, R. J. Munn, and M. B. Gardner. 1991. Experimental vaccine protection against feline immunodeficiency virus. AIDS Res. Hum. Retroviruses 7:911-921.
53. Zinkernagel, R. M., and H. Hengartner. 1994. Cell-mediated immunopathology versus direct cytolysis by virus-implications for HIV and AIDS. Immunol. Today 16:262-268.